Bangalore, Karnataka -- (SBWIRE) -- 05/18/2017 -- Human leukocyte antigen (HLA) is located in the chromosome 6, which is present in almost all nucleated cells. The HLA system includes a complex array of genes, which controls the immune response through recognition of self and non-self antigens, which can lead to graft rejection. HLA typing, also known as tissue typing, is required majorly to examine graft rejection due to organ, tissue, blood cell, and bone marrow transplantation. Through this testing, bone marrow and blood cell transplantation complications can be minimized, which can increase the survival rate of the organ recipient.

Report forecast the global HLA typing transplant market to grow at a CAGR of 9.20% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global HLA typing transplant market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of products such as systems, assays, and accessories.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global HLA Typing Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Immucor
- Illumina
- Thermo Fisher Scientific

Other prominent vendors
- Biofortuna
- Bio-Rad Laboratories
- Cellular Technology
- GenDx
- HistoGenetics
- InGen
- Linkage Biosciences
- Omixon
- Pacific Biosciences of California
- STRATEC Biomedical

Market driver
- Growing incidence of organ failure
- For a full, detailed list, view our report

Market challenge
- High cost of transplantation and unfavorable reimbursement policies
- For a full, detailed list, view our report

Market trend
- New government initiatives for HLA typing
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages "Global HLA Typing Transplant Market 2017-2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Market segmentation by products, Market segmentation by technology, Market segmentation by end-user, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-hla-typing-transplant-market-2017-2021

Find all Healthcare Reports at - http://www.drugpipeline.net/catalog/healthcare

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.